U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898853) titled 'The Effect of 0.1% Topical Ciclosporin a for 12-weeks on the Eye Surface Immune Cells in Dry Eyes' on March 09.
Brief Summary: Dry eye disease (DED) is a common, long-lasting condition that affects the surface of the eye. It happens when there's a problem with tear production or quality, which can lead to inflammation and discomfort. The immune system plays a big role in how DED develops and continues.
Researchers have found that in people with DED, there are more immune cells and inflammatory substances in the tears and on the eye's surface. This includes various types of immune cells, like T cells and dendritic cells, which are ...